Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethylated triazoles, offering significant cost reduction and scalable supply chain solutions for API manufacturing.
Patent CN110963943B details a mild, high-yield one-pot method for aryl amidines using nitrones and isocyanates, offering significant cost reduction and scalability for pharmaceutical intermediates.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.
Efficient Mn-catalyzed cyclization method for complex heterocycles. High yield, green chemistry, scalable production for pharma intermediates.
Patent CN110511193B reveals a mild elemental sulfur method for alpha-ketothioamides. Discover cost-effective pharma intermediate manufacturing with high purity.
Patent CN110194760B reveals a one-pot Pd-catalyzed route for isoindolinone intermediates, offering high yields and simplified supply chains for API manufacturing.
Novel copper-catalyzed route for allene thioethers offers mild conditions and high yields, ensuring reliable supply chain for complex API synthesis.
Patent CN114874139A details a green visible-light method for synthesizing dihydroisoquinoline intermediates, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Discover a novel metal-free synthetic method for quinoline oxides using sodium persulfate. Achieve high yields up to 97% with cost-effective, scalable processes for pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation method using sulfonyl chlorides avoids smelly thiols, offering cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN110724094A reveals a novel metal-free route for quinoline synthesis using diazocarbonyl compounds, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Patent CN107880039B reveals a heavy-metal-free route for pyrido triazinone compounds. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN110467613B reveals a mild nickel-catalyzed route for isoindolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112126941B introduces a green electrochemical method for synthesizing polysubstituted 10-hydroxyphenanthrene derivatives, offering cost reduction and high purity for pharmaceutical intermediates.
Patent CN113801050A reveals a copper-catalyzed method for highly functionalized beta-lactams, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.